Examining the frequency of blaCTX-M, blaTEM, and blaSHV genes in Escherichia coli isolates from patients in Tabriz hospitals, Iran

Year 2023, Volume: 40 Issue: 4, 734 - 739, 03.01.2024

Mahdiyeh Ebrahimzadeh Ghazal Pourbeiragh Abolfazl Jafarı-sales Mehrdad Pashazadeh

Abstract

Escherichia coli (E. coli ) is one of the most common hospital infections in which the emergence of antibiotic resistance and the prevalence of Extended Spectrum Beta-Lactamase (ESBL) are considered major problems in the control of hospital infections. The aim of this study was to investigate the frequency of blaCTX-M, blaTEM, and blaSHV beta-lactamase genes in E. coli isolated from different clinical samples by the combined disk and multiplex PCR methods. E. coli isolates from different clinical samples were collected over six months and identified with the help of standard microbiological and biochemical tests. The antibiotic resistance of E. coli isolates was determined by the disk diffusion method. The production of beta-lactamases was evaluated by the combined disk method, and the presence of blaCTX-M, blaTEM, and blaSHV genes was assessed by the multiplex PCR method. From the total of 200 examined samples, 114 E. coli isolates (57%) were identified with the highest resistance to ceftazidime, amikacin, cefotaxime, and tetracycline (100%) and the lowest resistance to imipenem (3.5%) and ampicillin (14%). 58 isolates (50.88%) were ESBL positive by phenotypic test, of which 20 isolates (34.48%) contained the blaTEM gene and 15 isolates (25.86%) contained the blaCTX-M gene. No positive blaSHV gene was observed in the samples. The presence of beta-lactamase genes examined in this study along with the occurrence of antibiotic resistance indicates the spread of bacterial resistance in the study area and shows the importance of rational antibiotic treatment.

Keywords

blaCTX-M, blaTEM, blaSHV, Escherichia coli, Beta-Lactamase

References

• 1. Sarvazad H, Darbouy M. Correlation of Antibiotic Resistance with SHV, CTX-M and TEM Extended-Spectrum Beta Lactamases Genes among Klebsiella pneumoniae Isolates from Patients in Kermanshah Hospitals. J Ardabil Univ Med Sci. 2017;17(3):353-62.
• 2. Sales AJ, Naebi S, Bannazadeh-Baghi H, Saki M. Antibiotic Resistance Pattern and Prevalence of blaOXA-51, blaNDM, blaVIM, blaPER, blaVEB, blaCTX, tetA and tetB Genes in Acinetobacter baumannii Isolated from Clinical Specimens of Hospitals in Tabriz city, Iran. J Clin Res Paramed Sci. 2021;10(2):e118521.
• 3. Jacobsen S, Stickler DJ, Mobley HL, Shirtliff M. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26-59.
• 4. Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;6:22-9.
• 5. Sales AJ, Naebi S, Nasiri R, Bannazadeh-Baghi H. The antibiotic resistance pattern and prevalence of blaTEM, blaSHV, blaCTX-M, blaPSE-1, sipB/C, and cmlA/tetR genes in Salmonella typhimurium isolated from children with diarrhea in Tabriz, Iran. Int J Health Sci. 2021;7(4):e118523.
• 6. Mirkalantari S, Masjedian F, Irajian G, Siddig EE, Fattahi A. Determination of the frequency of β-lactamase genes (bla SHV, bla TEM, bla CTX-M) and phylogenetic groups among ESBL-producing uropathogenic Escherichia coli isolated from outpatients. J Lab Med. 2020;44(1):27-33.
• 7. Nicolle LE. Antimicrobial resistance in community-acquired Escherichia coli isolated from urinary infection: Good news or bad?. Can J Infect Dis Med Microbiol. 2013;24:123-4.
• 8. Liyanage S. An investigation into the role of human papillomavirus in oesophageal squamous cell carcinoma: UNSW Sydney; 2014.
• 9. Shaikh S, Fatima J, Shakil S, Rizvi SMD, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90-101.
• 10. Jafari Sales A, Mobaiyen H. Frequency and resistance patterns in clinical isolates of Escherichia coli Extended Spectrum Beta Lactamase producing treatment Centers in Marand city, Iran. NCMBJ. 2017;7(26):19-26.
• 11. Jafari-Sales A, Bagherizadeh Y, Khalifehpour M, Abdoli-senejan M, Helali-Pargali R. Antibiotic resistance pattern and bla-TEM gene expression in Acinetobacter baumannii isolated from clinical specimens of Tabriz hospitals. Zanco J Med Sci. 2019;20(65):20-9.
• 12. Jafari Sales A, Jafari B, Beygoli N. Antimicrobial Resistance Patterns in Extended-spectrum βlactamase Producing Klebsiella pneumoniae Isolates in a Razi Hospital Marand, Iran. Electronic J Biol. 2015;11(1):8-12.
• 13. Jafari Sales A, Mobaiyen H, Farshbafi Nezhad Zoghi J, Nezamdoost Shadbad N, Purabdollah Kaleybar V. Antimicrobial resistance pattern of extended-spectrum β-Lactamases (ESBLs) producing Escherichia coli isolated from clinical samples in Tabriz city, Iran. Adv Environ Biol. 2014;8(16):179-82.
• 14. Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother. 2012;67(6):1311-20.
• 15. Sales A, Fathi R, Mobaiyen H, Bonab F, Kondlaji K. Molecular Study of the Prevalence of CTX-M1, CTX-M2, CTXM3 in Pseudomonas aeruginosa Isolated from Clinical Samples in Tabriz Town, Iran. Electronic J Biol. 2017;13(3):253-9.
• 16. Jafari-Sales A, Shadi-Dizaji A. Molecular analysis of CTX-M genes among ESBL producing in Pseudomonas aeru-ginosa isolated from clinical samples by Multiplex-PCR. Hozan J Environment Sci. 2018;2(5):17-29.
• 17. Dizaji AS, Fathi R, Sales AJ. Molecular study of extended-spectrum beta-lactamase (TEM-1) gene in Escherichia Coli isolates collected from Ostad Alinasab Hospital in Tabriz Iran. MMJ. 2016;29:35-40.
• 18. Jafari-Sales A, Bagherizadeh Y, Arzani-Birgani P, Shirali M, Shahniani AR. Study of Antibiotic Resistance and Prevalence of bla-TEM gene in Klebsiella pneumoniae Strains isolated from Children with UTI in Tabriz Hospitals. Focus Med Sci J. 2018;4(1):9-13.
• 19. Komijani M, Bouzari M, Rahimi F. Detection of TEM, SHV and CTX-M antibiotic resistance genes in Escherichia coli isolates from infected wounds. Med Lab J. 2017;11(2):30-5.
• 20. Jafari-Sales A, Khaneshpour H. Molecular Study of BlaIMP and BlaVIM Genes in Pseudomonas Aeruginosa Strains, Producer of Metallo Beta Lactamases Isolated from Clinical Samples in Hospitals and Medical Centers of Tabriz. Paramed Sci Mil Health. 2020;14(4):18-25.
• 21. Sadeghi-Deylamdeh Z, Jafari-Sales A. Evaluation of the presence of AmpC (FOX) beta-lactamase gene in clinical strains of Escherichia coli isolated from hospitalized patients in Tabriz. J Exp Clin Med. 2021;38(3):301-4.
• 22. Moubareck C, Daoud Z, Hakimé NI, Hamzé M, Mangeney N, Matta H, et al. Countrywide spread of community-and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol. 2005;43(7):3309-13.
• 23. Zaniani FR, Meshkat Z, Nasab MN, Khaje-Karamadini M, Ghazvini K, Rezaee A, et al. The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae. Iran. J Basic Med Sci. 2012;15(1):654.
• 24. Monstein HJ, Östholm‐Balkhed Å, Nilsson M, Nilsson M, Dornbusch K, Nilsson L. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX‐M genes in Enterobacteriaceae. Apmis. 2007;115(12):1400-8.
• 25. Geyer CN, Hanson ND. Rapid PCR amplification protocols decrease the turn-around time for detection of antibiotic resistance genes in Gram-negative pathogens. Diagn Microbiol Infect Dis. 2013;77(2):113-7.
• 26. Patel TS, Nagel JL. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs. J Clin Microbiol. 2015;53(1):201-5.
• 27. Kazemnia A, Ahmadi M, Dilmaghani M. Antibiotic resistance pattern of different Escherichia coli phylogenetic groups isolated from human urinary tract infection and avian colibacillosis. Iran Biomed J. 2014;18(4):219.
• 28. Rezai MS, Salehifar E, Rafiei A, Langaee T, Rafati M, Shafahi K, et al. Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. Biomed Res Int. 2015;2015.
• 29. Manoharan A, Premalatha K, Chatterjee S, Mathai D, Group SS. Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. IJMM. 2011;29(2):161-4.
• 30. Benenson S, Navon-Venezia S, Carmeli Y, Adler A, Strahilevitz J, Moses AE, et al. Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult: successful treatment with gentamicin and colistin. Int. J Infect Dis. 2009;13(5):e295-e8.
• 31. Kader AA, Kumar AK. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J. 2004;25(5):570-4.
• 32. Mortezavi R, Khosravani S, Naghavi N. Molecular analysis of gene frequencies of TEM, CTX-M and SHV in beta-lactam antibiotic-resistant strains of E. coli isolated from urinary tract infections in Yasuj hospitals. Armaghane Danesh. 2014;19(3):233-41.
• 33. Shabanpishe S, Rezaeian A. The prevalence and frequency of TEM and SHV beta-lactamase resistance genes and CTX-M in Enterobacteriaceae isolated from clinical samples in the laboratory kahooresten. NCMBJ. 2018;8(30):9-16.
• 34. Yazdi m, Nazemi A, Mir nargasi Ms, Khataminejad M, Sharifi S, Babai kochkaksaraei M. Prevalence of SHV/CTX-M/TEM (ESBL) Beta-lactamase Resistance Genes in Escherichia Coli Isolated from Urinary Tract Infections in Tehran, Iran. Med Lab J. 2010;4(1):3.
• 35. Moradi A, Ghiasian M, Ghandehari F. Molecular Identification of CTX-M and SHV Betalactamase Genes in Escherichia Coli Clinical Isolates in Isfahan. Armaghane Danesh. 2022;27(4):472-83.
• 36. Enyinnaya S, Iregbu K, Jamal W, Rotimi V. Antibiotic susceptibility profiles and detection of genes mediating extended-spectrum β-lactamase (Esbl) production in escherichia coli isolates from National Hospital, Abuja. Niger. J Clin Pract. 2022;25(8):1216-20.
• 37. Jalilian S, Rokh Bakhsh Zamin F. Evaluating the ability of Biofilm formation in Escherichia coli isolated from clinical samples in Zahedan. PJMS. 2022;15(1):36-42.
• 38. Ghaddar N, Anastasiadis E, Halimeh R, Ghaddar A, Matar GM, Abou Fayad A, et al. Phenotypic and genotypic characterization of extended-spectrum beta-lactamases produced by Escherichia coli colonizing pregnant women. Infect Dis Obstet Gynecol. 2020;2020:4190306.
• 39. Ghafourian S, Taheri Kalani M, Pakzad I, Sadeghifard N. Uropathogenic Bacterial and Antibiotic Resistance Pattern among patients Refereeing to Imam Khomaini Hospital, Ilam, Iran. Tec Re Inf Syst. 2022;5(1):15.
• 40. Mirsalehian A, Nakhjavani F. Frequency of extended spectrum β-Lactamase producing Enterobacteriaceae in intensive care units. Tehran Univ Med J. 2008;65(1):33-8.
• 41. Tasli H, Bahar IH. Molecular characterization of TEM-and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis. 2005;58(3):162.
• 42. Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP. Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis. 2004;49(3):217-22.
• 43. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39(6):1211-33.